Category: Greatbatch Inc.Syndicate content

Greatbatch requests CE Mark for spinal cord stim

January 20, 2014 by Chris Walker

Greatbatch files for European CE Mark for its spinal cord stimulation system, hoping to land marketing approval the treatment of chronic pain of the trunk and limbs.

Greatbatch submits spinal cord stim for CE Mark

Greatbatch (NYSE:GB) filed a CE Mark application for its spinal cord stimulation system with German notified body TÜV SÜD America.

Greatbatch submits PMA for spinal cord stim

December 19, 2013 by Chris Walker

Greatbatch files a pre-market approval application for its spinal cord neuromodulation system for treatment of chronic pain of the trunk and limbs.

Greatbatch filing PMA for spinal cord neuromodulation system

Greatbatch (NYSE:GB) this week filed a pre-market approval application with the FDA for its spinal cord neuromodulation system.

The neuromodulation system comes from the Frisco, Texas-based company's subsidiary, QiG Group, which hopes to win indication to treat chronic pain of the trunk and limbs.

Greatbatch gains on Q3 swing to black, earnings beat

October 25, 2013 by Brad Perriello

Greatbatch swings to 3rd-quarter profits and beats Wall Street's earnings expectations, sending share prices up today.

Greatbatch gains on Q3 swing to black, earnings beat

Greatbatch (NYSE:GB) shares are up this morning after the medical device company reported a profitable 3rd quarter and beat Wall Street's expectations for per-share earnings.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Uroplasty's new CFO hails from Synovis | Personnel Moves

August 13, 2013 by Sony Salzman

Uroplasty fills its chief finance officer spot with the former CFO of Synovis, a company acquired by Baxter.

fired/hired

Uroplasty (NSDQ:UPI) named Brett Reynolds to head its vacant finance chief position, drawing the new executive from his most recent gig as CFO at Baxter- (NYSE:BAX)acquired Synovis Life Technologies.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Greatbatch raises guidance on Q2 figures

July 30, 2013 by Sony Salzman

After releasing Q2 earnings, Texas medical device maker Greatbatch raises per-share guidance for the 2nd time in 2 months.

Greatbatch logo

Texas medical device maker Greatbatch (NYSE:GB) posted a profit in Q2 and nudged its 2013 per-share earnings guidance up for the 2nd time in 2 months. The device maker's Q2's sales eked out a 3% boost over last year's figures and profits were up 10%, according to the financial release.

Greatbatch raises 2013 guidance on restructuring efforts | Wall Street Beat

June 6, 2013 by Arezu Sarvestani

Greatbatch merges its sales, marketing and operations with subsidiary Electrochem in the interest of shifting from sub-assemblies to complete medical devices, raising its 2013 per-share earnings guidance.

MassDevice.com Wall Street Beat

Texas medical device maker Greatbatch (NYSE:GB) raised its 2013 per-share earnings guidance as it announced new efforts to reorganize some of its business practices and reduce costs as it shifts from a components and sub-assemblies company to a developer of full medical devices.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Edwards CEO Mussallem details U.S. Sapien sales guidance, updates on CoreValve case | Wall Street Beat

January 8, 2013 by MassDevice staff

Edwards Lifesciences CEO Michael Mussallem updates investors on U.S. sales expectations for its flagship Sapien heart valve and says the end might be near for its long legal battle with Medtronic's CoreValve over transcatheter aortic valve implant patents covering Sapien.

MassDevice.com Wall Street Beat

Edwards Lifesciences (NYSE:EW) chairman & CEO Michael Mussallem said the medical device company expects to post U.S. sales of $390 million-$440 million for its flagship Sapien heart valve, adding 200 new sites over the next 2 years to its existing roster of 200 sites.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp